INO

Inovio Pharmaceuticals

Last Updated:

Q3'20

Price

quotes and stock data delayed 15 minutes

Cash

$337.2M

Burn Rate (Qtr)

-$18M

Company Profile

INOVIO is a biotechnology company committed to powering a new way forward in DNA medicines to save and protect lives worldwide. The company is focused on rapidly bringing to market precisely designed and delivered DNA medicines to potentially treat and protect people from serious and life-threatening diseases associated with HPV, cancer, and infectious diseases.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

COVID-19 Vaccine

COVID-19

Phase 2/3 Initiation

TBD

VGX-3100

Precancerous Cervical Dysplasia (HSIL)

Phase 3 Data

H1 2021

INO-5401

Glioblastoma Multiforme (GBM)

Phase 2 (Data)

MEDI0457

Cervical, Anal, Penile, Vulvar Cancers

Phase 2

MEDI0457

Head & Neck Cancer

Phase 2

INO-4700 / GLS-5300

Middle East Respiratory Syndrome (MERS)

Phase 2 (Data)

INO-5151

Prostate Cancer

Phase 2 (Data)

GLS-5300 MERS coronavirus DNA vaccine

MERS

Phase 2

TBD

PENNVAX-GP

HIV (human immunodeficiency virus)

Phase 2 (Data)

VGX-3100

Precancerous Anal Dysplasia

Phase 2 (Data)

Q4 2020

VGX-3100

Precancerous Vulvar Dysplasia (HSIL)

Phase 2 (Data)

Q4 2020

INO-3107

Recurrent Respiratory Papillomatosis (RRP)

Phase 1/2

Recent Posts

See what the community is saying - click to see full post

BLPH - Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® fo

INO - INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO

Small Cap COVID-19 Vaccine Players

BLPH - Phase 2/3 Publication of Data in CHEST Journal

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon